Adenoviral Delivery of Angiotensin-(1-7) or Angiotensin-(1-9) Inhibits Cardiomyocyte Hypertrophy via the Mas or Angiotensin Type 2 Receptor

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Flores Muñoz, Monica ^a   Godinho, Bruno M D C ^a,b   Almalik, Abdulaziz ^a,c   Nicklin, Stuart A ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ADENOVIRUS VECTOR; ANGIOTENSIN DERIVATIVE; ANGIOTENSIN II; ANGIOTENSIN[1-7]; ANGIOTENSIN[1-7][7 DEXTRO ALANINE]; ANGIOTENSIN[1-9]; ARGIPRESSIN; HYBRID PROTEIN; ISOPRENALINE; UNCLASSIFIED DRUG;

ADULT ANIMAL; ANIMAL CELL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CULTURE MEDIUM; GENE TRANSFER; GENETIC TRANSDUCTION; HEART HYPERTROPHY; HEART MUSCLE CELL; INHIBITION KINETICS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; RABBIT; RAT; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS RECOMBINANT; WESTERN BLOTTING;

ADENOVIRIDAE; ANGIOTENSIN I; ANIMALS; CARDIOMEGALY; CELL LINE; GENETIC THERAPY; GENETIC VECTORS; HUMANS; MYOCYTES, CARDIAC; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS; RABBITS; RATS; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, G-PROTEIN-COUPLED; RECOMBINANT FUSION PROTEINS; TRANSDUCTION, GENETIC;

ORYCTOLAGUS CUNICULUS; RATTUS;

EID: 84866697003     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045564     Document Type: Article

References (25)

1. Grobe JL, Mecca AP, Lingis M, Shenoy V, Bolton TA, et al. (2007) Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7). Am J Physiol Heart Circ Physiol 292: H736-742.
2. Gurley SB, Allred A, Le TH, Griffiths R, Mao L, et al. (2006) Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice. J Clin Invest 116: 2218-2225.
3. Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, et al. (2003) Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A 100: 8258-8263.
4. Flores-Munoz M, Smith NJ, Haggerty C, Milligan G, Nicklin SA, (2011) Angiotensin1-9 antagonises pro-hypertrophic signalling in cardiomyocytes via the angiotensin type 2 receptor. J Physiol 589: 939-951.
5. Flores-Munoz M, Work LM, Douglas K, Denby L, Dominiczak AF, et al. (2012) Angiotensin-(1-9) attenuates cardiac fibrosis via the angiotensin type 2 receptor. Hypertension 59: 300-307.
6. Ferreira AJ, Pinheiro SV, Castro CH, Silva GA, Silva AC, et al. (2006) Renal function in transgenic rats expressing an angiotensin-(1-7)-producing fusion protein. Regul Pept 137: 128-133.
7. Lochard N, Silversides DW, van Kats JP, Mercure C, Reudelhuber TL, (2003) Brain-specific restoration of angiotensin II corrects renal defects seen in angiotensinogen-deficient mice. J Biol Chem 278: 2184-2189.
8. Mercure C, Yogi A, Callera GE, Aranha AB, Bader M, et al. (2008) Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart. Circ Res 103: 1319-1326.
9. Botelho-Santos GA, Sampaio WO, Reudelhuber TL, Bader M, Campagnole-Santos MJ, et al. (2007) Expression of an angiotensin-(1-7)-producing fusion protein in rats induced marked changes in regional vascular resistance. Am J Physiol Heart Circ Physiol 292: H2485-2490.
10. Santos RA, Ferreira AJ, Nadu AP, Braga AN, de Almeida AP, et al. (2004) Expression of an angiotensin-(1-7)-producing fusion protein produces cardioprotective effects in rats. Physiol Genomics 17: 292-299.
11. van Kats JP, Methot D, Paradis P, Silversides DW, Reudelhuber TL, (2001) Use of a biological peptide pump to study chronic peptide hormone action in transgenic mice. Direct and indirect effects of angiotensin II on the heart. J Biol Chem 276: 44012-44017.
12. Nadu AP, Ferreira AJ, Reudelhuber TL, Bader M, Santos RA, (2008) Reduced isoproterenol-induced renin-angiotensin changes and extracellular matrix deposition in hearts of TGR(A1-7)3292 rats. J Am Soc Hypertens 2: 341-348.
13. Santiago NM, Guimaraes PS, Sirvente RA, Oliveira LA, Irigoyen MC, et al. (2010) Lifetime overproduction of circulating Angiotensin-(1-7) attenuates deoxycorticosterone acetate-salt hypertension-induced cardiac dysfunction and remodeling. Hypertension 55: 889-896.
14. Ferreira AJ, Castro CH, Guatimosim S, Almeida PW, Gomes ER, et al. (2010) Attenuation of isoproterenol-induced cardiac fibrosis in transgenic rats harboring an angiotensin-(1-7)-producing fusion protein in the heart. Ther Adv Cardiovasc Dis.
15. Qi Y, Shenoy V, Wong F, Li H, Afzal A, et al. (2011) Lentiviral mediated overexpression of Angiotensin-(1-7) attenuated ischemia-induced cardiac pathophysiology. Exp Physiol.
16. Verma A, Shan Z, Lei B, Yuan L, Liu X, et al. (2011) ACE2 and Ang-(1-7) Confer Protection Against Development of Diabetic Retinopathy. Mol Ther.
17. Zou Y, Komuro I, Yamazaki T, Kudoh S, Uozumi H, et al. (1999) Both Gs and Gi proteins are critically involved in isoproterenol-induced cardiomyocyte hypertrophy. J Biol Chem 274: 9760-9770.
18. Hiroyama M, Wang S, Aoyagi T, Oikawa R, Sanbe A, et al. (2007) Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice. Eur J Pharmacol 559: 89-97.
19. Masson R, Nicklin SA, Craig MA, McBride M, Gilday K, et al. (2009) Onset of Experimental Severe Cardiac Fibrosis Is Mediated by Overexpression of Angiotensin-Converting Enzyme 2. Hypertension.
20. Takayanagi T, Bourne AM, Kimura K, Takaguri A, Elliott KJ, et al. (2012) Constitutive stimulation of vascular smooth muscle cells by angiotensin II derived from an adenovirus encoding a furin-cleavable fusion protein. Am J Hypertens 25: 280-283.
21. Palomeque J, Chemaly ER, Colosi P, Wellman JA, Zhou S, et al. (2007) Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo. Gene Ther 14: 989-997.
22. Methot D, LaPointe MC, Touyz RM, Yang XP, Carretero OA, et al. (1997) Tissue targeting of angiotensin peptides. J Biol Chem 272: 12994-12999.
23. Anderson RD, Haskell RE, Xia H, Roessler BJ, Davidson BL, (2000) A simple method for the rapid generation of recombinant adenovirus vectors. Gene Ther 7: 1034-1038.
24. George SJ, Wan S, Hu J, MacDonald R, Johnson JL, et al. (2011) Sustained reduction of vein graft neointima formation by ex vivo TIMP-3 gene therapy. Circulation 124: S135-142.
25. Nicklin SA, Baker AH (1999) Simple methods for preparing recombinant adenoviruses for high efficiency transduction of vascular cells. In: Baker AH, editor. Vascular Disease: Molecular Biology and Gene Therapy Protocols (Methods in Molecular Medicine). New York: Humana Press. 271-283.